Cargando…

Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer

This article considers the concept of designing Phase I clinical trials using both clinician- and patient-reported outcomes to adaptively allocate study participants to tolerable doses and determine the maximum tolerated dose (MTD) at the study conclusion. We describe an application of a Bayesian fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wages, Nolan A., Nelson, Bailey, Kharofa, Jordan, Meier, Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238853/ https://www.ncbi.nlm.nih.gov/pubmed/36394530 http://dx.doi.org/10.1515/ijb-2022-0023

Ejemplares similares

A web tool for designing and conducting phase I trials using the continual reassessment method
por: Wages, Nolan A., et al.
Publicado: (2018)

Local continual reassessment methods for dose finding and optimization in drug-combination trials
por: Zhang, Jingyi, et al.
Publicado: (2023)

Relationship of dose to vascular target volumes and local failure in pancreatic cancer patients undergoing neoadjuvant chemoradiation
por: Nelson, Bailey, et al.
Publicado: (2022)

A novel model of the continual reassessment method in Phase I trial
por: Zhang, Weijia, et al.
Publicado: (2023)

Extending the Continual Reassessment Method to accommodate step‐up dosing in Phase I trials
por: Braun, Thomas M., et al.
Publicado: (2022)

Implementation of the Time-to-Event Continuous Reassessment Method Design in a Phase I Platform Trial Testing Novel Radiotherapy-Drug Combinations—CONCORDE
por: Walker, Katrina, et al.
Publicado: (2022)

Dose Finding by the Continual Reassessment Method
por: Cheung, Ying
Publicado: (2011)

Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial
por: Mozgunov, Pavel, et al.
Publicado: (2022)

Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy
por: Bagley, Evan M., et al.
Publicado: (2021)

A Comprehensive Comparison of the Continual Reassessment Method to the Standard 3 + 3 Dose Escalation Scheme in Phase I Dose-Finding Studies
por: Iasonos, Alexia, et al.
Publicado: (2008)

The value of hybrid interstitial tandem and ring applicators for organ at risk dose reduction in small volume cervical cancer
por: Crossley, Najeeb, et al.
Publicado: (2020)

Bayesian Design for Identifying Cohort-Specific Optimal Dose Combinations Based on Multiple Endpoints: Application to a Phase I Trial in Non-Small Cell Lung Cancer
por: Horton, Bethany Jablonski, et al.
Publicado: (2021)

Reassessment of intensive surveillance practices adopted for endometrial cancer survivors
por: Nakamura, Kazuto, et al.
Publicado: (2022)

How to design a dose-finding study using the continual reassessment method
por: Wheeler, Graham M., et al.
Publicado: (2019)

Improving safety of the continual reassessment method via a modified allocation rule
por: Mozgunov, Pavel, et al.
Publicado: (2019)

A new pragmatic design for dose escalation in phase 1 clinical trials using an adaptive continual reassessment method
por: North, Bernard, et al.
Publicado: (2019)

A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research
por: Cai, Chunyan, et al.
Publicado: (2017)

Is It Time to Reassess the Role of Radiotherapy Treatment in Ovarian Cancer?
por: Macchia, Gabriella, et al.
Publicado: (2023)

The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach
por: Pan, Haitao, et al.
Publicado: (2014)

A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
por: Tang, Niansheng, et al.
Publicado: (2018)

Practicalities in running early-phase trials using the time-to-event continual reassessment method (TiTE-CRM) for interventions with long toxicity periods using two radiotherapy oncology trials as examples
por: van Werkhoven, Erik, et al.
Publicado: (2020)

Design considerations for early-phase clinical trials of immune-oncology agents
por: Wages, Nolan A., et al.
Publicado: (2018)

Reassessing the risk from rabies: A continuing threat to the UK?
por: Banyard, Ashley C., et al.
Publicado: (2010)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

Assessment of various continual reassessment method models for dose-escalation phase 1 oncology clinical trials: using real clinical data and simulation studies
por: James, G. D., et al.
Publicado: (2021)

Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial
por: Heilig, C.E., et al.
Publicado: (2021)

Treatment outcomes after adjuvant radiotherapy following surgery for patients with stage I endometrial cancer
por: Kim, Jiyoung, et al.
Publicado: (2016)

New perspectives for reassessing fosfomycin: applicability in current clinical practice
por: Candel, Francisco Javier, et al.
Publicado: (2019)

Postoperative radiotherapy for endometrial cancer
por: Choi, Eun Cheol, et al.
Publicado: (2012)

Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data
por: James, Gareth D., et al.
Publicado: (2016)

Reassessment of fluctuating dental asymmetry in Down syndrome
por: Matabuena Rodríguez, Marcos, et al.
Publicado: (2017)

Reassessing blood acetylcholinesterase in dementia
por: Han, Pengcheng
Publicado: (2015)

Reassessing carrier status for dystrophinopathies
por: Newcomb, Tara M., et al.
Publicado: (2016)

Reassessment of Pioglitazone for Alzheimer’s Disease
por: Saunders, Ann M., et al.
Publicado: (2021)

Reassessment of hyperautofluorescent rings in retinitis pigmentosa using novel retinal imaging techniques
por: Cabral, Diogo, et al.
Publicado: (2023)

Attribution of recent temperature behaviour reassessed by a neural-network method
por: Pasini, Antonello, et al.
Publicado: (2017)

Determination of the ED95 of intrathecal hyperbaric prilocaine with sufentanil for scheduled cesarean delivery: a dose-finding study based on the continual reassessment method
por: Goffard, P., et al.
Publicado: (2020)

Determinants of Sensitivity to Radiotherapy in Endometrial Cancer
por: Sorolla, Maria Alba, et al.
Publicado: (2020)

Continued use of IBV 793B vaccine needs reassessment after its withdrawal led to the genotype's disappearance
por: Franzo, Giovanni, et al.
Publicado: (2014)

Taxonomic Reinstatement of the Endemic Chinese Species Iris thoroldii (Iridaceae) from I. potaninii and Reassessment of I. zhaoana
por: Boltenkov, Eugeny V.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5eeirb5pdhmjh11rj9l9nhsct9